FrontPage is India's Stock Market Social Network
Join 50,000+ Traders and Investors

GODREJCP Consensus Forecast

No. of reports in last year
6
No. of analysts
4
Average Consensus Forecast
949.17
Consensus Potential
-14.72%

GODREJCP Price Target Potential

BrokerageTargetPotential
Motilal Oswal125015.64%
Sharekhan850-24.05%
Dolat Capital809-30.34%
Geojit Financial Services776-35.88%

GODREJCP Ratings

Long term GODREJCP rating by FrontPage users
4/5 (4 Ratings)

6 GODREJCP share price target reports by brokerages below. See what is analyst's view on GODREJCP share price forecast, rating, estimates, valuation and prediction behind the target. You may use these research report forecasts for long-term to medium term for your investment or trades in 2020.
  1. Home
  2. GODREJCP Forum
  3. GODREJCP Price Target

GODREJCP Share Price Target

GODREJCP Share Price Target - Broker Reports - 2021

30-Aug-21
Price @ Call: 1087
Target: 1250
BUY
5-Aug-21
Price @ Call: 976
Target: 1140
BUY
12-May-21
Price @ Call: 874.8
Target: 870
BUY
25-Mar-21
Price @ Call: 679.9
Target: 850
BUY
8-Feb-21
Price @ Call: 749.12
Target: 809
ACCUMULATE

GODREJCP Share Price Target - Broker Reports - 2020

11-Nov-20
Price @ Call: 677.55
Target: 776
BUY
26-May-20
Price @ Call: 579.53
Target: 665
BUY
The disruption of production activities and supply chain owing to the lockdown is expected to impact results for next few quarters. However, the company’s resilience has led to increase in the market share in key products. Internationally, Indonesia remains the key driver with increasing market share in few segments, however GAUM still faces headwinds. Given current upside potential, we upgrade our rating to BUY on the stock with a revised target price of Rs. 665 based on 35x FY22E adj. EPS.
... Read more
13-May-20
Price @ Call: 533.11
Target: 565
NEUTRAL
Godrej Consumer’s (GCPL) 4QFY20 results, while in line, offers no spark of structural revival. Similarly, management commentary also does not show any significant optimism on the company’s modest earnings growth trend (at 9.8% CAGR between FY15-20E) improving over the next two years.  With RoCE at ~16% in FY20 is significantly lower than peers and unlikely to increase sharply in the next two years. Thus, valuations of 33.2x FY22E EPS appear fair making us continue our Neutral view on the stock.
... Read more

GODREJCP Share Price Target - Broker Reports - 2019

6-Dec-19
Price @ Call: 672.67
Target: 865
BUY
Valuations look attractive, Maintain Buy: GCPL is focusing on improving its volume growth through innovations, enhancing distribution reach, and adequate brand-building and promotional activities in the near term. Receding concerns hovering around the domestic HI business (45% of the total domestic business) and international geographies performing well give us improved earnings visibility in the near term. Thus, we expect the company to report revenue and earnings CAGR of 11% and 17.2%, respectively over FY2019- 2022E. GCPL is currently trading at 33.6x its FY2021E earnings and 28.7x its FY2022E earnings, which is at a discount to its historical average. The muted performance of the past few quarters has already been factored in the current valuations of the stock. Hence, with reasonable voluations compared with sector P/E and expected improvement in business performance over the next two years, we maintain our Buy rating on the stock with an unchanged PT of Rs. 865.
... Read more
6-Nov-19
Price @ Call: 742.89
Target: 865
BUY
Valuation – Upgraded to Buy with revised Price Target of Rs. 865: We have broadly maintained our earnings estimates for FY2020 and FY2021. We have introduced FY2022 earnings estimates in this note. The company is focusing on improving its volume growth through innovations, enhancing the distribution reach and adequate brand building and promotional activities in the near term. Benign input prices would help the company clock better margins in the near term. The receding of concerns hovering around domestic HI business (45% of total domestic business) and international geographies performing well gives us improved earnings visibility in the near term. Hence, with modest P/E upgrade and roll over factor (valuing stock at 40x average of FY2021/22 earnings), we upgrade our rating on the stock to Buy from Hold with revised price target (PT) of Rs. 865.
... Read more
2-Aug-19
Price @ Call: 602.47
Target: 650
HOLD
Valuation: As expected, GCPL posted yet another quarter of muted performance affected by dismal performance of the domestic HI category, soft performance by hair colour category and slower growth in international business. We have reduced our earnings estimates by ~2% each for FY2020 and FY2021 to factor in a slower recovery in the domestic HI category and international business. In view of nearterm headwinds, we maintain our Hold recommendation on the stock with a revised price target of Rs. 650 (valuing stock at 34x its FY2021E earnings). Any fast recovery in the domestic HI space would act as a key trigger for the stock.
... Read more
1-Jul-19
Price @ Call: 668.77
Target: 734
HOLD
Maintain Hold with an unchanged PT of Rs. 734: GCPL continuesto record subdued numbers since the past few quarters as on tepid demand for household insecticides due to increased competition from illegal incense sticks and a rural slowdown in the domestic market. Growth in the international market was also affected by currency headwinds and macro concerns in key geographies. Demand for HI is expected to get back on track led by corrective steps the company has undertaken while recovery in the Indonesian business and double-digit growth in Africa will revive international business growth. However the revival would be gradual as Q1FY2020 is expected to be yet another subdued quarter for GCPL with revenue expected to remain flat and OPM expected to be drop by ~83 bps y-o-y. The stock is trading at a discounted valuation of 34.3x its FY2021E EPS. We maintain our Hold recommendation on the stock with an unchanged price target (PT) of Rs. 734.
... Read more
14-Jun-19
Price @ Call: 664.96
Target: 700
NEUTRAL
While the stock price is down nearly 30% from its peak, there is yet no clear indication that earnings slowdown (7% PBT growth in the past three years) will turn around materially in FY20 to anywhere close to earlier levels. During FY08- 16, the company reported over 20% CAGR growth on all fronts — Sales, EBITDA, PAT and EPS. The other factor is that majority of the CCC cycle improvement has come in from higher creditor days. GCPL’s efforts to reduce inventory days, particularly in the African business is yet to make a substantial impact on the consolidated level. This offers an opportunity for significant improvement if plans for further reduction in inventory days in Africa pan out as targeted, and particularly, if topline growth revives as well. Valuations of 34.7x FY21, while cheaper than peer average, offers limited upside on considering weaker than best of breed peer earnings visibility and less than peer ROCE levels (at least currently). Maintain Neutral.
... Read more
6-May-19
Price @ Call: 642.15
Target: 734
HOLD
Road to recovery will take time, maintain Hold: The steps undertaken by GCPL to revive the growth of key categories (HI in India and haircare in Africa) will take time to show desired results. We expect revival in performance from H2FY2020 as the slowdown in the rural market will continue to affect the performance in the near term in the domestic market. We have reduced our earnings estimates for FY2020 and FY2021 by 6.6% and 7.2% respectively to factor in lower than expected growth in the key categories. The stock is currently trading at 31.5x its FY2021E earnings. We maintain our Hold recommendation on the stock with revised PT of Rs. 734 (valuing the stock at 36x its FY2021E earnings).
... Read more
4-Feb-19
Price @ Call: 700.56
Target: 835
ACCUMULATE
30-Jan-19
Price @ Call: 757.3
Target: 805
NEUTRAL
Changes to model have led to 3.2%/2.3% cut in FY19/FY20 EPS. At 42.8x FY20 EPS, the stock is not undervalued, particularly as earnings growth (earlier more consistent than FMCG peers) has come off over the last couple of years. In addition, GCPL’s exposure to various geographies, attendant currency risks and relatively lower RoE (early-20’s) compared to peers demands a check on target multiples. Maintain Neutral with a revised target price of INR805 (41x Dec’20 EPS, 5% discount to 3-year average multiple).
... Read more

GODREJCP Share Price Target - Broker Reports - 2018

6-Dec-18
Price @ Call: 752.2
Target: 807
HOLD
29-Aug-18
Price @ Call: 957.15
Target: 1100
BUY
3-Aug-18
Price @ Call: 884.74
Target: 1014
ACCUMULATE
31-Jul-18
Price @ Call: 874.6
Target: 1026.67
BUY
31-Jul-18
Price @ Call: 874.6
Target: 968
BUY
30-Jul-18
Price @ Call: 871.6
Target: 925.33
ACCUMULATE
12-Jul-18
Price @ Call: 883.13
Target: 956.67
BUY
10-May-18
Price @ Call: 728.4
Target: 770
NEUTRAL
8-May-18
Price @ Call: 744.64
Target: 843.33
BUY
8-May-18
Price @ Call: 744.64
Target: 833.33
BUY
9-May-18
Price @ Call: 748.7
Target: 796
ACCUMULATE
7-Mar-18
Price @ Call: 724.67
Target: 795.33
BUY
30-Jan-18
Price @ Call: 704.88
Target: 710
NEUTRAL
31-Jan-18
Price @ Call: 707.33
Target: 802
BUY
20-Jan-18
Price @ Call: 697.21
Target: 816.67
BUY

GODREJCP Share Price Target - Broker Reports - 2017

7-Dec-17
Price @ Call: 666.75
Target: 746.67
BUY
3-Nov-17
Price @ Call: 646.75
Target: 746.67
BUY
1-Nov-17
Price @ Call: 646.93
Target: 676.67
NEUTRAL
2-Nov-17
Price @ Call: 642
Target: 740.67
BUY
6-Sep-17
Price @ Call: 620
Target: 546.67
SELL
31-Jul-17
Price @ Call: 691.33
Target: 722.67
BUY
1-Aug-17
Price @ Call: 690
Target: 746.67
BUY
10-May-17
Price @ Call: 962.5
Target: 1045
BUY
9-May-17
Price @ Call: 964.5
Target: 1004
BUY
30-Jan-17
Price @ Call: 802
Target: 802.5
ACCUMULATE

GODREJCP Share Price Target - Broker Reports - 2016

4-May-16
Price @ Call: 670.4
Target: 625
SELL
13-Dec-16
Price @ Call: 720.5
Target: 805
NEUTRAL
7-Nov-16
Price @ Call: 760.5
Target: 820
HOLD
7-Nov-16
Price @ Call: 760.5
Target: 799.5
ACCUMULATE
7-Nov-16
Price @ Call: 760.5
Target: 849
BUY
18-Aug-16
Price @ Call: 764.43
Target: 900
BUY
Join FrontPage
Hero Img
FrontPage is India's favorite stock discussions community
Join 2,00,000 Indian traders and discuss trades, strategies, news & views on any stock.
  • GODREJCP Share Price Target Today- Technical Pivot Points (Classic)

    keyboard_arrow_down
    Upside Target 31,076.3
    Upside Target 21,071.15
    Upside Target 11,064.6
    Pivot1,059.45
    Downside Target 11,052.9
    Downside Target 21,047.75
    Downside Target 31,041.2
  • GODREJCP Share Price Target weekly- Technical Pivot Points (Classic)

    keyboard_arrow_down
    Upside Target 31,180.13
    Upside Target 21,159.07
    Upside Target 11,124.83
    Pivot1,103.77
    Downside Target 11,069.53
    Downside Target 21,048.47
    Downside Target 31,014.23
  • GODREJCP Share Price Target monthly- Technical Pivot Points (Classic)

    keyboard_arrow_down
    Upside Target 31,290.13
    Upside Target 21,195.07
    Upside Target 11,147.18
    Pivot1,052.12
    Downside Target 11,004.23
    Downside Target 2909.17
    Downside Target 3861.28
  • GODREJCP Share Price Target today- Technical Pivot Points (Fibonacci)

    keyboard_arrow_down
    Upside Target 31,071.15
    Upside Target 21,066.68
    Upside Target 11,063.92
    Pivot1,059.45
    Downside Target 11,054.98
    Downside Target 21,052.22
    Downside Target 31,047.75
  • GODREJCP Share Price Target weekly- Technical Pivot Points (Fibonacci)

    keyboard_arrow_down
    Upside Target 31,159.07
    Upside Target 21,137.94
    Upside Target 11,124.89
    Pivot1,103.77
    Downside Target 11,082.64
    Downside Target 21,069.59
    Downside Target 31,048.47
  • GODREJCP Share Price Target monthly- Technical Pivot Points (Fibonacci)

    keyboard_arrow_down
    Upside Target 31,195.07
    Upside Target 21,140.46
    Upside Target 11,106.72
    Pivot1,052.12
    Downside Target 1997.51
    Downside Target 2963.77
    Downside Target 3909.17
SOURCE: Data from D'Market via Quandl. Intraday data delayed 15 minutes.
DISCLAIMER: Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and FrontPage will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein.
PrivacyTerms
FrontPage © 2020